Peter Whitehouse

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Green Robert C; Roberts J Scott; Cupples L Adrienne; Relkin Norman R; Whitehouse Peter J; Brown Tamsen; Eckert Susan LaRusse; Butson Melissa; Sadovnick A Dessa; Quaid Kimberly A; Chen Clara; Cook-Deegan Robert; Farrer Lindsay A;
Disclosure of APOE genotype for risk of Alzheimer's disease.
Whitehouse Peter J; George Daniel
Banking on stories for healthier cognitive ageing.
Stocking Carol B; Hougham Gavin W; Danner Deborah D; Patterson Marion B; Whitehouse Peter J; Sachs Greg A
Variable judgments of decisional capacity in cognitively impaired research subjects.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Peter Whitehouse (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Green Robert C; Roberts J Scott; Cupples L Adrienne; Relkin Norman R; Whitehouse Peter J; Brown Tamsen; Eckert Susan LaRusse; Butson Melissa; Sadovnick A Dessa; Quaid Kimberly A; Chen Clara; Cook-Deegan Robert; Farrer Lindsay A;
Disclosure of APOE genotype for risk of Alzheimer's disease.
The New England journal of medicine 2009;361(3):245-54.
2009: Whitehouse Peter J; George Daniel
Banking on stories for healthier cognitive ageing.
Lancet 2009;373(9670):1166-7.
2008: Stocking Carol B; Hougham Gavin W; Danner Deborah D; Patterson Marion B; Whitehouse Peter J; Sachs Greg A
Variable judgments of decisional capacity in cognitively impaired research subjects.
Journal of the American Geriatrics Society 2008;56(10):1893-7.
2008: Whitehouse Peter J
National Institute of Health and Clinical Excellence decision processes supported by UK High Court: the debate about the value of Alzheimer's disease drugs continues.
Journal of Alzheimer's disease : JAD 2008;13(3):239-40.
2008: Dawson Neal V; Singer Mendel E; Lenert Leslie; Patterson Marian B; Sami Susie A; Gonsenhouser Iahn; Lindstrom Heather A; Smyth Kathleen A; Barber Melissa J; Whitehouse Peter J
Health state valuation in mild to moderate cognitive impairment: feasibility of computer-based, direct patient utility assessment.
Medical decision making : an international journal of the Society for Medical Decision Making 2008;28(2):220-32.
2008: Christensen Kurt D; Roberts J Scott; Royal Charmaine D M; Fasaye Grace-Ann; Obisesan Thomas; Cupples L Adrienne; Whitehouse Peter J; Butson Melissa Barber; Linnenbringer Erin; Relkin Norman R; Farrer Lindsay; Cook-Deegan Robert; Green Robert C
Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.
Genetics in medicine : official journal of the American College of Medical Genetics 2008;10(3):207-14.
2008: Whitehouse Peter J
Why I no longer consult for drug companies.
Culture, medicine and psychiatry 2008;32(1):4-10.
2008: Campbell Kellie H; Stocking Carol B; Hougham Gavin W; Whitehouse Peter J; Danner Deborah D; Sachs Greg A
Dementia, diagnostic disclosure, and self-reported health status.
Journal of the American Geriatrics Society 2008;56(2):296-300.
2008: Whitehouse Peter J; Sami Susie A
Quality of life in dementias.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2008;89():97-100.
2007: Stocking Carol B; Hougham Gavin W; Danner Deborah D; Patterson Marian B; Whitehouse Peter J; Sachs Greg A
Empirical assessment of a research advance directive for persons with dementia and their proxies.
Journal of the American Geriatrics Society 2007;55(10):1609-12.
2007: Whitehouse Peter J; Waller Sara
Involuntary emotional expressive disorder: a case for a deeper neuroethics.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2007;4(3):560-7.
2007: Whitehouse Peter J
Commentary: integrative narrative evolutionary health: toward a wiser view of Alzheimer's disease.
Journal of alternative and complementary medicine (New York, N.Y.) 2007;13(3):341-4.
2007: Whitehouse Peter J
Mild cognitive impairment--a confused concept?
Nature clinical practice. Neurology 2007;3(2):62-3.
2006: Eckert Susan LaRusse; Katzen Heather; Roberts J Scott; Barber Melissa; Ravdin Lisa D; Relkin Norman R; Whitehouse Peter J; Green Robert C
Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study.
Genetics in medicine : official journal of the American College of Medical Genetics 2006;8(12):746-51.
2006: Whitehouse Peter J; Rajcan Julia L; Sami Susie A; Patterson Marian B; Smyth Kathleen A; Edland Steven D; George Daniel R
ADCS Prevention Instrument Project: pilot testing of a book club as a psychosocial intervention and recruitment and retention strategy.
Alzheimer disease and associated disorders 2006;20(4 Suppl 3):S203-8.
2006: Sano Mary; Zhu Carolyn W; Whitehouse Peter J; Edland Steven; Jin Shelia; Ernstrom Karin; Thomas Ronald G; Thal Leon J; Ferris Steven H;
ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly.
Alzheimer disease and associated disorders 2006;20(4 Suppl 3):S191-202.
2006: Patterson Marian B; Whitehouse Peter J; Edland Steven D; Sami Susie A; Sano Mary; Smyth Kathleen; Weiner Myron F;
ADCS Prevention Instrument Project: quality of life assessment (QOL).
Alzheimer disease and associated disorders 2006;20(4 Suppl 3):S179-90.
2006: Ferris Steven H; Aisen Paul S; Cummings Jeffrey; Galasko Douglas; Salmon David P; Schneider Lon; Sano Mary; Whitehouse Peter J; Edland Steven; Thal Leon J;
ADCS Prevention Instrument Project: overview and initial results.
Alzheimer disease and associated disorders 2006;20(4 Suppl 3):S109-23.
2006: Whitehouse Peter J
The end of AD. Part 3.
Alzheimer disease and associated disorders 2006;20(4):195-8.
2006: Whitehouse Peter; Brodaty Henry
Mild cognitive impairment.
Lancet 2006;367(9527):1979.
2006: Stocking C B; Hougham G W; Danner D D; Patterson M B; Whitehouse P J; Sachs G A
Speaking of research advance directives: planning for future research participation.
Neurology 2006;66(9):1361-6.
2006: Gauthier Serge; Reisberg Barry; Zaudig Michael; Petersen Ronald C; Ritchie Karen; Broich Karl; Belleville Sylvie; Brodaty Henry; Bennett David; Chertkow Howard; Cummings Jeffrey L; de Leon Mony; Feldman Howard; Ganguli Mary; Hampel Harald; Scheltens Philip; Tierney Mary C; Whitehouse Peter; Winblad Bengt;
Mild cognitive impairment.
Lancet 2006;367(9518):1262-70.
2006: Whitehouse Peter J
Quality of life: the bridge from the cholinergic basal forebrain to cognitive science and bioethics.
Journal of Alzheimer's disease : JAD 2006;9(3 Suppl):447-53.
2005: Roberts J Scott; Cupples L Adrienne; Relkin Norman R; Whitehouse Peter J; Green Robert C;
Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.
Journal of geriatric psychiatry and neurology 2005;18(4):250-5.
2005: Whitehouse Peter J; Juengst Eric T
Antiaging medicine and mild cognitive impairment: practice and policy issues for geriatrics.
Journal of the American Geriatrics Society 2005;53(8):1417-22.
2005: Whitehouse Peter J; Gaines Atwood D; Lindstrom Heather; Graham Janice E
Anthropological contributions to the understanding of age-related cognitive impairment.
Lancet neurology 2005;4(5):320-6.
2005: LaRusse Susan; Roberts J Scott; Marteau Theresa M; Katzen Heather; Linnenbringer Erin L; Barber Melissa; Whitehouse Peter; Quaid Kimberly; Brown Tamsen; Green Robert C; Relkin Norman R
Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(1):48-53.
2004: Karlawish Jason; Whitehouse Peter; McShane Rupert H
Silence science: the problem of not reporting negative trials.
Alzheimer disease and associated disorders 2004;18(4):180-2.
2004: Roberts J Scott; Barber Melissa; Brown Tamsen M; Cupples L Adrienne; Farrer Lindsay A; LaRusse Susan A; Post Stephen G; Quaid Kimberly A; Ravdin Lisa D; Relkin Norman R; Sadovnick A Dessa; Whitehouse Peter J; Woodard John L; Green Robert C
Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial.
Genetics in medicine : official journal of the American College of Medical Genetics 2004;6(4):197-203.
2004: Cupples L Adrienne; Farrer Lindsay A; Sadovnick A Dessa; Relkin Norman; Whitehouse Peter; Green Robert C
Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.
Genetics in medicine : official journal of the American College of Medical Genetics 2004;6(4):192-6.
2004: Mehlman Maxwell J; Binstock Robert H; Juengst Eric T; Ponsaran Roselle S; Whitehouse Peter J
Anti-aging medicine: can consumers be better protected?
The Gerontologist 2004;44(3):304-10.
2004: Whitehouse Peter; Frisoni Giovanni B; Post Stephen
Breaking the diagnosis of dementia.
Lancet neurology 2004;3(2):124-8.
2004: Lee J H; Friedland R; Whitehouse P J; Woo J I
Twenty-four-hour rhythms of sleep-wake cycle and temperature in Alzheimer's disease.
The Journal of neuropsychiatry and clinical neurosciences 2004;16(2):192-8.
2004: Whitehouse Peter J; Fishman Jennifer R
Justice and the house of medicine: the mortgaging of ecology and economics.
The American journal of bioethics : AJOB 2004;4(2):43-5.
2004: Whitehouse P J
Paying attention to acetylcholine: the key to wisdom and quality of life?
Progress in brain research 2004;145():311-7.
2003: Whitehouse Peter J; Patterson Marian B; Sami Susie A
Quality of life in dementia: ten years later.
Alzheimer disease and associated disorders 2003;17(4):199-200.
2003: Hougham Gavin W; Sachs Greg A; Danner Deborah; Mintz Jim; Patterson Marian; Roberts Laura W; Siminoff Laura A; Sugarman Jeremy; Whitehouse Peter J; Wirshing Donna
Empirical research on informed consent with the cognitively impaired.
IRB 2003;Suppl 25(5):S26-S32.
2003: Juengst Eric T; Binstock Robert H; Mehlman Maxwell; Post Stephen G; Whitehouse Peter
Biogerontology, "anti-aging medicine," and the challenges of human enhancement.
The Hastings Center report 2003;33(4):21-30.
2003: Whitehouse Peter J
MSJAMA: Lessons and responses in Alzheimer disease research.
JAMA : the journal of the American Medical Association 2003;290(1):115.
2003: Whitehouse Peter J;
Research advances in the neurology of dementia.
Alzheimer disease and associated disorders 2003;17(2):127-8.
2003: Roberts J Scott; LaRusse Susan A; Katzen Heather; Whitehouse Peter J; Barber Melissa; Post Stephen G; Relkin Norman; Quaid Kimberly; Pietrzak Robert H; Cupples L Adrienne; Farrer Lindsay A; Brown Tamsen; Green Robert C
Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.
Alzheimer disease and associated disorders 2003;17(2):86-93.
2003: Whitehouse Peter J
Classification of the dementias.
Lancet 2003;361(9364):1227.
2003: Whitehouse Peter J
The rebirth of bioethics: extending the original formulations of Van Rensselaer Potter.
The American journal of bioethics : AJOB 2003;3(4):W26-W31.
2003: Szatmari S Z; Whitehouse P J
Vinpocetine for cognitive impairment and dementia.
Cochrane database of systematic reviews (Online) 2003;(1):CD003119.
2002: Karlawish Jason H T; Knopman David; Clark Christopher M; Morris John C; Marson Daniel; Whitehouse Peter J; Kawas Claudia H
Informed consent for Alzheimer's disease clinical trials: a survey of clinical investigators.
IRB 2002;24(5):1-5.
2002: Yesavage J A; Mumenthaler M S; Taylor J L; Friedman L; O'Hara R; Sheikh J; Tinklenberg J; Whitehouse P J
Donepezil and flight simulator performance: effects on retention of complex skills.
Neurology 2002;59(1):123-5.
2002: Barber Melissa; Whitehouse Peter J
Susceptibility testing for Alzheimer's disease: race for the future.
Lancet neurology 2002;1(1):10.
2002: Whitehouse Peter J
Van Rensselaer Potter: an intellectual memoir.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 2002;11(4):331-4.
2002: Whitehouse Peter J
The evolution of gene patenting.
The American journal of bioethics : AJOB 2002;2(3):23-4.
2001: Whitehouse P J
The end of Alzheimer disease II: commentary on "Decisions to treat or not to treat pneumonia in demented psychogeriatric nursing home patients".
Alzheimer disease and associated disorders 2001;15(3):118.
2001: Doody R S; Stevens J C; Beck C; Dubinsky R M; Kaye J A; Gwyther L; Mohs R C; Thal L J; Whitehouse P J; DeKosky S T; Cummings J L
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology 2001;56(9):1154-66.
2001: Mack J L; Whitehouse P J
Quality of Life in Dementia: state of the art--report of the International Working Group for Harmonization of Dementia Drug Guidelines and the Alzheimer's Society satellite meeting.
Alzheimer disease and associated disorders 2001;15(2):69-71.
2001: Whitehouse P J
The end of Alzheimer disease.
Alzheimer disease and associated disorders 2001;15(2):59-62.
2001: Post S G; Stuckey J C; Whitehouse P J; Ollerton S; Durkin C; Robbins D; Fallcreek S J
A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers.
Alzheimer disease and associated disorders 2001;15(2):80-8.
2000: Teri L; Logsdon R G; Peskind E; Raskind M; Weiner M F; Tractenberg R E; Foster N L; Schneider L S; Sano M; Whitehouse P; Tariot P; Mellow A M; Auchus A P; Grundman M; Thomas R G; Schafer K; Thal L J;
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.
Neurology 2000;55(9):1271-8.
2000: Jönsson L; Jönsson B; Wimo A; Whitehouse P; Winblad B
Second International Pharmacoeconomic Conference on Alzheimer' s Disease.
Alzheimer disease and associated disorders 2000;14(3):137-40.
2000: Whitehouse P J
New models for a new age.
Alzheimer disease and associated disorders 2000;14(2):59.
2000: Whitehouse P J
Harmonization of Dementia Drug Guidelines (United States and Europe): a report of the International Working Group for the Harmonization for Dementia Drug Guidelines.
Alzheimer disease and associated disorders 2000;14 Suppl 1():S119-22.
1999: Gauthier S; Rockwood K; Gélinas I; Sykes L; Teunisse S; Orgogozo J M; Erkinjuntti T; Erzigkeit H; Gleeson M; Kittner B; Pontecorvo M; Feldman H; Whitehouse P
Outcome measures for the study of activities of daily living in vascular dementia.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S143-7.
1999: Erkinjuntti T; Sawada T; Whitehouse P J
The Osaka Conference on Vascular Dementia 1998.
Alzheimer disease and associated disorders 1999;13 Suppl 3():S1-3.
1999: Hinze S W; Gaines A D; Lerner A J; Whitehouse P J
An interdisciplinary response to the Reagan Research Institute Report on Women and Alzheimer's Disease.
Alzheimer disease and associated disorders 1999;13(4):183-6.
1999: Ballenger J F; Nelson J L; Whitehouse P J
Beyond "progress" in the history of Alzheimer disease.
Alzheimer disease and associated disorders 1999;13(3):130-1.
1999: Kawas C H; Clark C M; Farlow M R; Knopman D S; Marson D; Morris J C; Thal L J; Whitehouse P J
Clinical trials in Alzheimer disease: debate on the use of placebo controls.
Alzheimer disease and associated disorders 1999;13(3):124-9.
1999: Whitehouse P J; Arizaga R; Brodaty H; Gauthier S; Graham N; Green R C; Homma A; Mangone C; Senanarong V; Xu X H
Placebos in clinical trials in Alzheimer disease: an international discussion.
Alzheimer disease and associated disorders 1999;13(3):121-3.
1999: Brodaty H; Dresser R; Eisner M; Erkunjuntti T; Gauthier S; Graham N; Jonker C; Sachs G; Whitehouse P
Alzheimer's Disease International and International Working Group for Harmonization of Dementia Drug Guidelines for research involving human subjects with dementia.
Alzheimer disease and associated disorders 1999;13(2):71-9.
1999: Cohen C A; Whitehouse P J; Post S G; Gauthier S; Eberhart A; LeDuc L
Ethical issues in Alzheimer disease: the experience of a national Alzheimer society task force.
Alzheimer disease and associated disorders 1999;13(2):66-70.
1999: Post S G; Whitehouse P J; Nelson J L; Sachs G A
Alzheimer disease ethics: a continuing area of public interest.
Alzheimer disease and associated disorders 1999;13(2):63-5.
1999: Whitehouse P J
Alzheimer's disease: past, present, and future.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 3():43-5.
1999: Post S G; Whitehouse P J
Spirituality, religion, and Alzheimer's disease.
Journal of health care chaplaincy 1999;8(1-2):45-57.
1998: Gaines A D; Whitehouse P J
Harmony and consensus: cultural aspects of organization in international science.
Alzheimer disease and associated disorders 1998;12(4):295-301.
1998: Whitehouse P J; Kittner B; Roessner M; Rossor M; Sano M; Thal L; Winblad B
Clinical trial designs for demonstrating disease-course-altering effects in dementia.
Alzheimer disease and associated disorders 1998;12(4):281-94.
1998: Whitehouse P J; Winblad B; Shostak D; Bhattacharjya A; Brod M; Brodaty H; Dor A; Feldman H; Forette F; Gauthier S; Hay J; Henke C; Hill S; Mastey V; Neumann P; O'Brien B; Pugner K; Sano M; Sawada T; Stone R; Wimo A
First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary.
Alzheimer disease and associated disorders 1998;12(4):266-80.
1998: Doody R; Whitehouse P J; Chen Q; Wang L; Wu Q; Rosser M; Xu X H
Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1998;12(4):263-5.
1998: Harvey R J; Whitehouse P J; Rossor M N
Report of the European Working Group on Dementia Drug Guidelines Meeting--Brussels, November 1997.
Alzheimer disease and associated disorders 1998;12(4):259-61.
1998: Weiner M F; Koss E; Patterson M; Jin S; Teri L; Thomas R; Thal L J; Whitehouse P
A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease.
Journal of psychiatric research 1998;32(6):347-51.
1998: Karlawish J H; Whitehouse P J
Is the placebo control obsolete in a world after donepezil and vitamin E?
Archives of neurology 1998;55(11):1420-4.
1998: Post S G; Whitehouse P J
Emerging antidementia drugs: a preliminary ethical view.
Journal of the American Geriatrics Society 1998;46(6):784-7.
1998: Whitehouse P J
Donepezil.
Drugs of today (Barcelona, Spain : 1998) 1998;34(4):321-6.
1998: Smith A L; Whitehouse P J
Progress in the management of Alzheimer's disease.
Hospital practice (1995) 1998;33(3):151-4, 157-66.
1998: Kitamura Y; Shimohama S; Kamoshima W; Ota T; Matsuoka Y; Nomura Y; Smith M A; Perry G; Whitehouse P J; Taniguchi T
Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease.
Brain research 1998;780(2):260-9.
1998: Whitehouse P J
The cholinergic deficit in Alzheimer's disease.
The Journal of clinical psychiatry 1998;59 Suppl 13():19-22.
1997: Hay J W; Sano M; Whitehouse P J
The costs and social burdens of Alzheimer disease: what can and should be done?
Alzheimer disease and associated disorders 1997;11(4):181-3.
1997: Geldmacher D S; Lerner A J; Voci J M; Noelker E A; Somple L C; Whitehouse P J
Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs.
Journal of geriatric psychiatry and neurology 1997;10(3):99-104.
1997: Sehgal A R; Grey S F; DeOreo P B; Whitehouse P J
Prevalence, recognition, and implications of mental impairment among hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;30(1):41-9.
1997: Whitehouse P J; Reidenbach F
Guidelines for early identification of Alzheimer Disease.
Alzheimer disease and associated disorders 1997;11(2):61-2.
1997: Whitehouse P J; Juengst E; Mehlman M; Murray T H
Enhancing cognition in the intellectually intact.
The Hastings Center report 1997;27(3):14-22.
1997: Whitehouse P J
Genesis of Alzheimer's disease.
Neurology 1997;48(5 Suppl 7):S2-7.
1997: Geldmacher D S; Whitehouse P J
Differential diagnosis of Alzheimer's disease.
Neurology 1997;48(5 Suppl 6):S2-9.
1997: Dresser R; Whitehouse P
Emergency research and research involving subjects with cognitive impairment: ethical connections and contrasts.
Journal of the American Geriatrics Society 1997;45(4):521-3.
1997: Post S G; Whitehouse P J; Binstock R H; Bird T D; Eckert S K; Farrer L A; Fleck L M; Gaines A D; Juengst E T; Karlinsky H; Miles S; Murray T H; Quaid K A; Relkin N R; Roses A D; St George-Hyslop P H; Sachs G A; Steinbock B; Truschke E F; Zinn A B
The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.
JAMA : the journal of the American Medical Association 1997;277(10):832-6.
1997: Burns A; Whitehouse P; Arendt T; Försti H
Alzheimer's disease in senile dementia: loss of neurones in the basal forebrain. Whitehouse, P., Price, D., Struble, R., Clarke, A., Coyle, J. and Delong, M. Science (1982), 215, 1237-1239.
International journal of geriatric psychiatry 1997;12(1):7-10.
1997: Maslow K; Whitehouse P
Defining and measuring outcomes in Alzheimer disease research: conference findings.
Alzheimer disease and associated disorders 1997;11 Suppl 6():186-95.
1997: Smyth K A; Ferris S H; Fox P; Heyman A; Holmes D; Morris J N; Phillips C D; Schulz R; Teresi J; Whitehouse P J
Measurement choices in multi-site studies of outcomes in dementia.
Alzheimer disease and associated disorders 1997;11 Suppl 6():30-44.
1997: Whitehouse P; Maslow K
Defining and measuring outcomes in Alzheimer disease research: introduction and overview.
Alzheimer disease and associated disorders 1997;11 Suppl 6():1-6.
1997: Whitehouse P J
Pharmacoeconomics of dementia.
Alzheimer disease and associated disorders 1997;11 Suppl 5():S22-32; discussion S32-3.
1997: Whitehouse P J; Orgogozo J M; Becker R E; Gauthier S; Pontecorvo M; Erzigkeit H; Rogers S; Mohs R C; Bodick N; Bruno G; Dal-Bianco P
Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():56-60.
1997: Bodick N; Forette F; Hadler D; Harvey R J; Leber P; McKeith I G; Riekkinen P J; Rossor M N; Scheltens P; Shimohama S; Spiegel R; Tanaka S; Thal L J; Urata Y; Whitehouse P; Wilcock G
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.
Alzheimer disease and associated disorders 1997;11 Suppl 3():50-3.
1997: Harvey R J; Sciulli C G; Mason R M; Whitehouse P J
Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():29-32.
1997: Post S G; Beerman B; Brodaty H; Gaines A W; Gauthier S G; Geldmacher D S; Hill S; Homma A; Rossor M N; Whitehouse P J; Winblad B
Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer disease and associated disorders 1997;11 Suppl 3():26-8.
1997: Whitehouse P J
The International Working Group on Harmonization of Dementia Drug Guidelines: past, present, and future.
Alzheimer disease and associated disorders 1997;11 Suppl 3():2-5.
1997: Mackell J A; Ferris S H; Mohs R; Schneider L; Galasko D; Whitehouse P; Schmitt F; Sano M; Thal L J
Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S65-9.
1997: Koss E; Weiner M; Ernesto C; Cohen-Mansfield J; Ferris S H; Grundman M; Schafer K; Sano M; Thal L J; Thomas R; Whitehouse P J
Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S45-50.
1997: Patterson M B; Mack J L; Mackell J A; Thomas R; Tariot P; Weiner M; Whitehouse P J
A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S40-4.
1997: Ferris S H; Mackell J A; Mohs R; Schneider L S; Galasko D; Whitehouse P J; Schmitt F A; Sano M; Thomas R G; Ernesto C; Grundman M; Schafer K; Thal L J
A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study.
Alzheimer disease and associated disorders 1997;11 Suppl 2():S1-12.
1997: Whitehouse P J; Sciulli C G; Mason R M
Dementia drug development: use of information systems to harmonize global drug development.
Psychopharmacology bulletin 1997;33(1):129-33.
1996: Kodish E; Murray T; Whitehouse P
Conflict of interest in university-industry research relationships: realities, politics, and values.
Academic medicine : journal of the Association of American Medical Colleges 1996;71(12):1287-90.
1996: Geldmacher D S; Whitehouse P J
Evaluation of dementia.
The New England journal of medicine 1996;335(5):330-6.
1996: Mehlman M J; Kodish E D; Whitehouse P; Zinn A B; Sollitto S; Berger J; Chiao E J; Dosick M S; Cassidy S B
The need for anonymous genetic counseling and testing.
American journal of human genetics 1996;58(2):393-7.
1996: Whitehouse P J; Patterson M B; Strauss M E; Geldmacher D S; Mack J L; Gilmore G C; Koss E
Hallucinations.
International psychogeriatrics / IPA 1996;8 Suppl 3():387-92.
1996: Weiner M F; Koss E; Wild K V; Folks D G; Tariot P; Luszczynska H; Whitehouse P
Measures of psychiatric symptoms in Alzheimer patients: a review.
Alzheimer disease and associated disorders 1996;10(1):20-30.
1996: Whitehouse P J; Post S G; Sachs G A
Dementia care at the end of life: empirical research and international collaboration.
Alzheimer disease and associated disorders 1996;10(1):3-4.
1996: Whitehouse P J; Morris J C
Disclosure of financial interest: a new policy for Alzheimer disease and associated disorders.
Alzheimer disease and associated disorders 1996;10(1):1-2.
1996: Whitehouse P J
Future prospects for Alzheimer's disease therapy: ethical and policy issues for the international community.
Acta neurologica Scandinavica. Supplementum 1996;165():145-9.
1996: Ku Y; Whitehouse P J
Complementary therapeutic alternatives: what can we learn?
Alzheimer disease and associated disorders 1996;10(2):61-2.
1995: Post S G; Whitehouse P J
Fairhill guidelines on ethics of the care of people with Alzheimer's disease: a clinical summary. Center for Biomedical Ethics, Case Western Reserve University and the Alzheimer's Association.
Journal of the American Geriatrics Society 1995;43(12):1423-9.
1995: Shimohama S; Fujimoto S; Chachin M; Taniguchi T; Perry G; Whitehouse P J; Kimura J
Alterations of low molecular weight acid phosphatase protein level in Alzheimer's disease.
Brain research 1995;699(1):125-9.
1995: Whitehouse P J; Deal W E
Situated beyond modernity: lessons for Alzheimer's disease research.
Journal of the American Geriatrics Society 1995;43(11):1314-5.
1995: Whitehouse P J; Voci J
Therapeutic trials in Alzheimer's disease.
Current opinion in neurology 1995;8(4):275-8.
1995: Shimohama S; Fujimoto S; Matsushima H; Takenawa T; Taniguchi T; Perry G; Whitehouse P J; Kimura J
Alteration of phospholipase C-delta protein level and specific activity in Alzheimer's disease.
Journal of neurochemistry 1995;64(6):2629-34.
1995: Ripich D N; Petrill S A; Whitehouse P J; Ziol E W
Gender differences in language of AD patients: a longitudinal study.
Neurology 1995;45(2):299-302.
1995: Gilmore G C; Whitehouse P J
Contrast sensitivity in Alzheimer's disease: a 1-year longitudinal analysis.
Optometry and vision science : official publication of the American Academy of Optometry 1995;72(2):83-91.
1995: Shimohama S; Perry G; Richey P; Praprotnik D; Takenawa T; Fukami K; Whitehouse P J; Kimura J
Characterization of the association of phospholipase C-delta with Alzheimer neurofibrillary tangles.
Brain research 1995;669(2):217-24.
1995: Whitehouse P J; Kalaria R N
Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications.
Alzheimer disease and associated disorders 1995;9 Suppl 2():3-5.
1995: Whitehouse P J
Should we differentiate subtypes of Alzheimer disease?
Alzheimer disease and associated disorders 1995;9 Suppl 1():S1.
1994: Ownby R L; Koss E; Smyth K A; Whitehouse P J
The factor structure of the Brief Psychiatric Rating Scale in Alzheimer's disease.
Journal of geriatric psychiatry and neurology 1994;7(4):245-50.
1994: Lanska D J; Currier R D; Cohen M; Gambetti P; Smith E E; Bebin J; Jackson J F; Whitehouse P J; Markesbery W R
Familial progressive subcortical gliosis.
Neurology 1994;44(9):1633-43.
1994: Kalaria R N; Homayoun P; Whitehouse P J
Nicotinic cholinergic receptors associated with mammalian cerebral vessels.
Journal of the autonomic nervous system 1994;49 Suppl():S3-7.
1994: Dresser R; Whitehouse P J
The incompetent patient on the slippery slope.
The Hastings Center report 1994;24(4):6-12.
1994: Whitehouse P J; Geldmacher D S
Pharmacotherapy for Alzheimer's disease.
Clinics in geriatric medicine 1994;10(2):339-50.
1994: Lerner A J; Koss E; Patterson M B; Ownby R L; Hedera P; Friedland R P; Whitehouse P J
Concomitants of visual hallucinations in Alzheimer's disease.
Neurology 1994;44(3 Pt 1):523-7.
1994: High Dallas M; Whitehouse Peter J; Post Stephen G; Berg Leonard
Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper.
Alzheimer disease and associated disorders 1994;8(Suppl. 4):66-74.
1994: Post Stephen G; Ripich Danielle N; Whitehouse Peter J
Discourse ethics: research, dementia, and communication.
Alzheimer disease and associated disorders 1994;8(Suppl. 4):58-65.
1994: High Dallas M; Post Stephen G; Whitehouse Peter J
Introduction (to 6 articles and a position paper on ethical and legal issues in Alzheimer disease research)
Alzheimer disease and associated disorders 1994;8(Suppl. 4):1-4.
1994: Martin Richard J; Gwyther Lisa P; Whitehouse Peter J
Special care unit research: ethical issues.
Alzheimer disease and associated disorders 1994;8(Suppl. 1):S360-7.
1994: Martin R J; Gwyther L P; Whitehouse P J
Special care unit research: ethical issues.
Alzheimer disease and associated disorders 1994;8 Suppl 1():S360-7.
1994: Patterson M B; Whitehouse P J
Behavioral symptoms in dementia: theories and therapies.
Alzheimer disease and associated disorders 1994;8 Suppl 3():1-3.
1994: High D M; Whitehouse P J; Post S G; Berg L
Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper. National Institute on Aging.
Alzheimer disease and associated disorders 1994;8 Suppl 4():66-74.
1994: Post S G; Ripich D N; Whitehouse P J
Discourse ethics: research, dementia, and communication.
Alzheimer disease and associated disorders 1994;8 Suppl 4():58-65.
1994: High D M; Post S G; Whitehouse P J
Ethical and legal issues in Alzheimer disease research. Introduction.
Alzheimer disease and associated disorders 1994;8 Suppl 4():1-4.
1993: Mack J L; Patterson M B; Schnell A H; Whitehouse P J
Performance of subjects with probable Alzheimer disease and normal elderly controls on the Gollin Incomplete Pictures Test.
Perceptual and motor skills 1993;77(3 Pt 1):951-69.
1993: Shimohama S; Perry G; Richey P; Takenawa T; Whitehouse P J; Miyoshi K; Suenaga T; Matsumoto S; Nishimura M; Kimura J
Abnormal accumulation of phospholipase C-delta in filamentous inclusions of human neurodegenerative diseases.
Neuroscience letters 1993;162(1-2):183-6.
1993: Kennedy J S; Strauss M E; Smyth K A; Whitehouse P J
The relationship of clinical psychopathologic rating and cognitive factors to clinical dementia staging.
Progress in neuro-psychopharmacology & biological psychiatry 1993;17(5):775-9.
1993: Shimohama S; Fujimoto S; Tresser N; Richey P; Perry G; Whitehouse P J; Homma Y; Takenawa T; Taniguchi T; Suenaga T
Aberrant phosphoinositide metabolism in Alzheimer's disease.
Annals of the New York Academy of Sciences 1993;695():46-9.
1993: Whitehouse P J
Autopsy.
The Gerontologist 1993;33(4):436-7.
1993: Koss E; Patterson M B; Ownby R; Stuckey J C; Whitehouse P J
Memory evaluation in Alzheimer's disease. Caregivers' appraisals and objective testing.
Archives of neurology 1993;50(1):92-7.
1993: Whitehouse P J; Landreth G; Younkin S
Molecular biology of Alzheimer's disease.
Molecular genetic medicine 1993;3():95-137.
1993: Whitehouse P J
Cholinergic therapy in dementia.
Acta neurologica Scandinavica. Supplementum 1993;149():42-5.
1992: Cohen M; Lanska D; Roessmann U; Karaman B; Ganz E; Whitehouse P; Gambetti P
Amyloidoma of the CNS. I. Clinical and pathologic study.
Neurology 1992;42(10):2019-23.
1992: Davis K L; Thal L J; Gamzu E R; Davis C S; Woolson R F; Gracon S I; Drachman D A; Schneider L S; Whitehouse P J; Hoover T M
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
The New England journal of medicine 1992;327(18):1253-9.
1992: Chatterjee A; Strauss M E; Smyth K A; Whitehouse P J
Personality changes in Alzheimer's disease.
Archives of neurology 1992;49(5):486-91.
1992: Post S G; Botkin J R; Whitehouse P
Selective abortion for familial Alzheimer disease?
Obstetrics and gynecology 1992;79(5 ( Pt 1)):794-8.
1992: Mendez M F; Martin R J; Smyth K A; Whitehouse P J
Disturbances of person identification in Alzheimer's disease. A retrospective study.
The Journal of nervous and mental disease 1992;180(2):94-6.
1992: Post S G; Whitehouse P J
Dementia and the life-prolonging technologies used: an ethical question.
Alzheimer disease and associated disorders 1992;6(1):3-6.
1992: Patterson M B; Mack J L; Neundorfer M M; Martin R J; Smyth K A; Whitehouse P J
Assessment of functional ability in Alzheimer disease: a review and a preliminary report on the Cleveland Scale for Activities of Daily Living.
Alzheimer disease and associated disorders 1992;6(3):145-63.
1992: Whitehouse P J; Rabins P V
Quality of life and dementia.
Alzheimer disease and associated disorders 1992;6(3):135-7.
1992: Teri L; Rabins P; Whitehouse P; Berg L; Reisberg B; Sunderland T; Eichelman B; Phelps C
Management of behavior disturbance in Alzheimer disease: current knowledge and future directions.
Alzheimer disease and associated disorders 1992;6(2):77-88.
1992: Patterson M B; Whitehouse P J
Behavioral symptoms in Alzheimer disease: a look ahead.
Alzheimer disease and associated disorders 1992;6(2):71-2.
1992: Whitehouse P J
Alzheimer's disease: relationship of cognition and behavior to neurochemistry.
International psychogeriatrics / IPA 1992;4 Suppl 1():71-8.
1992: Lerner A J; Friedland R P; Whitehouse P J
Uses of biological markers.
Alzheimer disease and associated disorders 1992;6(4):197-200.
1991: Piletz J E; Sarasua M; Whitehouse P; Chotani M
Intracellular membranes are more fluid in platelets of Alzheimer's disease patients.
Neurobiology of aging 1991;12(5):401-6.
1991: Whitehouse P J
Geriatric neurology.
Neurology 1991;41(8):1169-70.
1991: Ripich D N; Vertes D; Whitehouse P; Fulton S; Ekelman B
Turn-taking and speech act patterns in the discourse of senile dementia of the Alzheimer's type patients.
Brain and language 1991;40(3):330-43.
1991: Whitehouse P J
Pathology in the cholinergic basal forebrain: implications for treatment.
Advances in experimental medicine and biology 1991;295():447-52.
1991: Whitehouse P J
Treatment of Alzheimer disease.
Alzheimer disease and associated disorders 1991;5 Suppl 1():S32-6.
1990: Wagster M V; Whitehouse P J; Walker L C; Kellar K J; Price D L
Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1990;10(9):2879-85.
1990: Mendez M F; Mendez M A; Martin R; Smyth K A; Whitehouse P J
Complex visual disturbances in Alzheimer's disease.
Neurology 1990;40(3 Pt 1):439-43.
1990: Patterson M B; Schnell A H; Martin R J; Mendez M F; Smyth K A; Whitehouse P J
Assessment of behavioral and affective symptoms in Alzheimer's disease.
Journal of geriatric psychiatry and neurology 1990;3(1):21-30.
1990: Jarvik L F; Berg L; Bartus R; Heston L; Leith N; Phelps C; Shader R; Whitehouse P
Clinical drug trials in Alzheimer disease. What are some of the issues?
Alzheimer disease and associated disorders 1990;4(4):193-202.
1990: Mendez M F; Martin R J; Smyth K A; Whitehouse P J
Psychiatric symptoms associated with Alzheimer's disease.
The Journal of neuropsychiatry and clinical neurosciences 1990;2(1):28-33.
1990: Palmert M R; Podlisny M B; Golde T E; Cohen M L; Kovacs D M; Tanzi R E; Gusella J F; Whitehouse P J; Witker D S; Oltersdorf T
Analysis of the beta-amyloid protein precursor of Alzheimer's disease: mRNAs and protein products.
Advances in neurology 1990;51():181-4.
1989: Teng E L; Wimer C; Roberts E; Damasio A R; Eslinger P J; Folstein M F; Tune L E; Whitehouse P J; Bardolph E L; Chui H C
Alzheimer's dementia: performance on parallel forms of the dementia assessment battery.
Journal of clinical and experimental neuropsychology 1989;11(6):899-912.
1989: Kalaria R N; Andorn A C; Tabaton M; Whitehouse P J; Harik S I; Unnerstall J R
Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus.
Journal of neurochemistry 1989;53(6):1772-81.
1989: Atack J R; Wenk G L; Wagster M V; Kellar K J; Whitehouse P J; Rapoport S I
Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study.
Brain research 1989;483(2):367-72.
1989: Powers R E; Powell S K; Schlough C N; Whitehouse P J
Autopsy services for dementia patients.
The Gerontologist 1989;29(1):120-3.
1989: Whitehouse P J
Parkinson's disease and Alzheimer's disease: new neurochemical parallels.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S57-62.
1989: Onorato M; Mulvihill P; Connolly J; Galloway P; Whitehouse P; Perry G
Alteration of neuritic cytoarchitecture in Alzheimer disease.
Progress in clinical and biological research 1989;317():781-9.
1989: Zweig R M; Ross C A; Hedreen J C; Steele C; Cardillo J E; Whitehouse P J; Folstein M F; Price D L
Neuropathology of aminergic nuclei in Alzheimer's disease.
Progress in clinical and biological research 1989;317():353-65.
1989: Whitehouse P J; Gambetti P; Harik S I; Kalaria R N; Perry G; Younkin S I; Tabaton M; Unnerstall J R
Neurochemistry of dementia: establishing the links.
Progress in clinical and biological research 1989;317():131-42.
1989: Palmert M R; Podlisny M B; Golde T E; Cohen M L; Kovacs D M; Tanzi R E; Gusella J F; Whitehouse P J; Witker D S; Oltersdorf T
The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
Progress in clinical and biological research 1989;317():971-84.
1988: Casanova M F; Struble R G; Whitehouse P J; Price D L
A historical perspective on the neuropathology of dementia with emphasis on the senile plaque.
Boletín de la Asociación Médica de Puerto Rico 1988;80(11):424-8.
1988: Tabaton M; Whitehouse P J; Perry G; Davies P; Autilio-Gambetti L; Gambetti P
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.
Annals of neurology 1988;24(3):407-13.
1988: Whitehouse P J
Specific neurochemical systems and memory.
Neurobiology of aging 1988;9(5-6):639-40.
1988: Zweig R M; Ross C A; Hedreen J C; Steele C; Cardillo J E; Whitehouse P J; Folstein M F; Price D L
The neuropathology of aminergic nuclei in Alzheimer's disease.
Annals of neurology 1988;24(2):233-42.
1988: Whitehouse P J; Martino A M; Marcus K A; Zweig R M; Singer H S; Price D L; Kellar K J
Reductions in acetylcholine and nicotine binding in several degenerative diseases.
Archives of neurology 1988;45(7):722-4.
1988: Whitehouse P J; Martino A M; Wagster M V; Price D L; Mayeux R; Atack J R; Kellar K J
Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study.
Neurology 1988;38(5):720-3.
1988: Zweig R M; Hedreen J C; Jankel W R; Casanova M F; Whitehouse P J; Price D L
Pathology in brainstem regions of individuals with primary dystonia.
Neurology 1988;38(5):702-6.
1988: Whitehouse P J
Intraventricular bethanechol in Alzheimer's disease: a continuing controversy.
Neurology 1988;38(2):307-8.
1988: Smyth K; Whitehouse P J; Rust M; Kahana J
Epidemiology, diagnosis, and management of Alzheimer's disease and related disorders: implications for minority populations.
Health matrix 1988;6(4):28-32.
1988: Hedreen J C; Zweig R M; DeLong M R; Whitehouse P J; Price D L
Primary dystonias: a review of the pathology and suggestions for new directions of study.
Advances in neurology 1988;50():123-32.
1988: Whitehouse P J; Unnerstall J R
Neurochemistry of dementia.
European neurology 1988;28 Suppl 1():36-41.
1987: Kellar K J; Whitehouse P J; Martino-Barrows A M; Marcus K; Price D L
Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
Brain research 1987;436(1):62-8.
1987: De Souza E B; Whitehouse P J; Folstein S E; Price D L; Vale W W
Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease.
Brain research 1987;437(2):355-9.
1987: Unnerstall J R; Whitehouse P J
New approaches to quantitative neuropathology: multivariate analysis of morphologic and neurochemical measures.
Neurobiology of aging 1987;8(6):567-9.
1987: Whitehouse P J
Reviewing the "breakthroughs" in Alzheimer's research.
Geriatrics 1987;42(9):107, 110-1.
1987: D'Amato R J; Zweig R M; Whitehouse P J; Wenk G L; Singer H S; Mayeux R; Price D L; Snyder S H
Aminergic systems in Alzheimer's disease and Parkinson's disease.
Annals of neurology 1987;22(2):229-36.
1987: Zweig R M; Whitehouse P J; Casanova M F; Walker L C; Jankel W R; Price D L
Loss of pedunculopontine neurons in progressive supranuclear palsy.
Annals of neurology 1987;22(1):18-25.
1987: Wand G S; May C; May V; Whitehouse P J; Rapoport S I; Eipper B A
Alzheimer's disease: low levels of peptide alpha-amidation activity in brain and CSF.
Neurology 1987;37(6):1057-61.
1987: Whitehouse P J; Vale W W; Zweig R M; Singer H S; Mayeux R; Kuhar M J; Price D L; De Souza E B
Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy.
Neurology 1987;37(6):905-9.
1987: Trifiletti R R; Snowman A M; Whitehouse P J; Marcus K A; Snyder S H
Huntington's disease: increased number and altered regulation of benzodiazepine receptor complexes in frontal cerebral cortex.
Neurology 1987;37(6):916-22.
1987: Price D L; Cork L C; Struble R G; Kitt C A; Walker L C; Powers R E; Whitehouse P J; Griffin J W
Dysfunction and death of neurons in human degenerative neurological diseases and in animal models.
Ciba Foundation symposium 1987;126():30-48.
1987: Powers R E; Walker L C; DeSouza E B; Vale W W; Struble R G; Whitehouse P J; Price D L
Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease.
Synapse (New York, N.Y.) 1987;1(5):405-10.
1987: De Souza E B; Whitehouse P J; Price D L; Vale W W
Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders.
Annals of the New York Academy of Sciences 1987;512():237-47.
1987: Whitehouse P J; Kellar K J
Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders.
Journal of neural transmission. Supplementum 1987;24():175-82.
1987: Whitehouse P J
Alzheimer's disease, a multisystem disorder: implications for therapy.
Psychopharmacology bulletin 1987;23(1):15-8.
1987: Whitehouse P J
Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
Advances in neurology 1987;45():393-7.
1987: Whitehouse P J
Neurotransmitter receptor alterations in Alzheimer disease: a review.
Alzheimer disease and associated disorders 1987;1(1):9-18.
1986: Clark A W; White C L; Manz H J; Parhad I M; Curry B; Whitehouse P J; Lehmann J; Coyle J T
Primary degenerative dementia without Alzheimer pathology.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):462-70.
1986: Lyon R A; Titeler M; Frost J J; Whitehouse P J; Wong D F; Wagner H N; Dannals R F; Links J M; Kuhar M J
3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1986;6(10):2941-9.
1986: Uhl G R; Hackney G O; Torchia M; Stranov V; Tourtellotte W W; Whitehouse P J; Tran V; Strittmatter S
Parkinson's disease: nigral receptor changes support peptidergic role in nigrostriatal modulation.
Annals of neurology 1986;20(2):194-203.
1986: Whitehouse P J
Understanding the etiology of Alzheimer's disease. Current approaches.
Neurologic clinics 1986;4(2):427-37.
1986: Whitehouse P J; Martino A M; Antuono P G; Lowenstein P R; Coyle J T; Price D L; Kellar K J
Nicotinic acetylcholine binding sites in Alzheimer's disease.
Brain research 1986;371(1):146-51.
1986: De Souza E B; Whitehouse P J; Kuhar M J; Price D L; Vale W W
Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
Nature 1986;319(6054):593-5.
1986: Whitehouse P J; Muramoto O; Troncoso J C; Kanazawa I
Neurotransmitter receptors in olivopontocerebellar atrophy: an autoradiographic study.
Neurology 1986;36(2):193-7.
1986: Whitehouse P J
The concept of subcortical and cortical dementia: another look.
Annals of neurology 1986;19(1):1-6.
1986: Whitehouse P J; Au K S
Cholinergic receptors in aging and Alzheimer's disease.
Progress in neuro-psychopharmacology & biological psychiatry 1986;10(3-5):665-76.
1986: Price D L; Struble R G; Whitehouse P J; Kitt C A; Cork L C; Walker L C; Casanova M F
Alzheimer's disease: a multisystem disorder.
Research publications - Association for Research in Nervous and Mental Disease 1986;64():209-14.
1985: Casanova M F; Walker L C; Whitehouse P J; Price D L
Abnormalities of the nucleus basalis in Down's syndrome.
Annals of neurology 1985;18(3):310-3.
1985: Whitehouse P J; Trifiletti R R; Jones B E; Folstein S; Price D L; Snyder S H; Kuhar M J
Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
Annals of neurology 1985;18(2):202-10.
1985: Batshaw M L; Wachtel R C; Deckel A W; Whitehouse P J; Moses H; Fochtman L J; Eldridge R
Munchausen's syndrome simulating torsion dystonia.
The New England journal of medicine 1985;312(22):1437-9.
1985: De Souza E B; Perrin M H; Whitehouse P J; Rivier J; Vale W; Kuhar M J
Corticotropin-releasing factor receptors in human pituitary gland: autoradiographic localization.
Neuroendocrinology 1985;40(5):419-22.
1985: Whitehouse P J; Wamsley J K; Zarbin M A; Price D L; Kuhar M J
Neurotransmitter receptors in amyotrophic lateral sclerosis: possible relationship to sparing of eye movements.
Annals of neurology 1985;17(5):518.
1985: Whitehouse P J
Theodor Meynert: foreshadowing modern concepts of neuropsychiatric pathophysiology.
Neurology 1985;35(3):389-91.
1985: Price D L; Cork L C; Struble R G; Whitehouse P J; Kitt C A; Walker L C
The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease.
Annals of the New York Academy of Sciences 1985;444():287-95.
1985: Whitehouse P J; Struble R G; Hedreen J C; Clark A W; Price D L
Alzheimer's disease and related dementias: selective involvement of specific neuronal systems.
CRC critical reviews in clinical neurobiology 1985;1(4):319-39.
1985: Price D L; Kitt C A; Struble R G; Whitehouse P J; Cork L C; Walker L C
Neurobiological studies of transmitter systems in aging and in Alzheimer-type dementia.
Annals of the New York Academy of Sciences 1985;457():35-51.
1985: Price D L; Whitehouse P J; Struble R G
Alzheimer's disease.
Annual review of medicine 1985;36():349-56.
1984: Whitehouse P J; Lynch D; Kuhar M J
Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process.
Journal of neurochemistry 1984;43(2):553-9.
1984: Uhl G R; Whitehouse P J; Price D L; Tourtelotte W W; Kuhar M J
Parkinson's disease: depletion of substantia nigra neurotensin receptors.
Brain research 1984;308(1):186-90.
1984: Hedreen J C; Struble R G; Whitehouse P J; Price D L
Topography of the magnocellular basal forebrain system in human brain.
Journal of neuropathology and experimental neurology 1984;43(1):1-21.
1983: Uhl G R; Hilt D C; Hedreen J C; Whitehouse P J; Price D L
Pick's disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert.
Neurology 1983;33(11):1470-3.
1983: Folstein M F; Whitehouse P J
Cognitive impairment of Alzheimer disease.
Neurobehavioral toxicology and teratology 1983;5(6):631-4.
1983: Niehoff D L; Whitehouse P J
Multiple benzodiazepine receptors: autoradiographic localization in normal human amygdala.
Brain research 1983;276(2):237-45.
1983: Clark A W; Parhad I M; Folstein S E; Whitehouse P J; Hedreen J C; Price D L; Chase G A
The nucleus basalis in Huntington's disease.
Neurology 1983;33(10):1262-7.
1983: Whitehouse P J; Wamsley J K; Zarbin M A; Price D L; Tourtellotte W W; Kuhar M J
Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors.
Annals of neurology 1983;14(1):8-16.
1983: Whitehouse P J; Hedreen J C; White C L; Price D L
Basal forebrain neurons in the dementia of Parkinson disease.
Annals of neurology 1983;13(3):243-8.
1983: Whitehouse P J; Struble R G; Hedreen J C; Clark A W; White C L; Parhad I M; Price D L
Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease.
Psychopharmacology bulletin 1983;19(3):437-40.
1982: Whitehouse P J; Struble R G; Clark A W; Price D L
Alzheimer disease: plaques, tangles, and the basal forebrain.
Annals of neurology 1982;12(5):494.
1982: Whitehouse P J; Bleecker M L
Co-occurring ophthalmoplegia and hemiparesis in a case of migraine.
Archives of neurology 1982;39(7):445-6.
1982: Struble R G; Cork L C; Whitehouse P J; Price D L
Cholinergic innervation in neuritic plaques.
Science (New York, N.Y.) 1982;216(4544):413-5.
1982: Whitehouse P J; Price D L; Struble R G; Clark A W; Coyle J T; Delon M R
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.
Science (New York, N.Y.) 1982;215(4537):1237-9.
1982: Price D L; Whitehouse P J; Struble R G; Coyle J T; Clark A W; Delong M R; Cork L C; Hedreen J C
Alzheimer's disease and Down's syndrome.
Annals of the New York Academy of Sciences 1982;396():145-64.
1981: LaFrance N D; Wagner H N; Whitehouse P; Corley E; Duelfer T
Decreased accumulation of isopropyl-lodoamphetamine (I-123) in brain tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1981;22(12):1081-3.
1981: Whitehouse P J
Imagery and verbal encoding in left and right hemisphere damaged patients.
Brain and language 1981;14(2):315-32.
1981: Whitehouse P J; Price D L; Clark A W; Coyle J T; DeLong M R
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.
Annals of neurology 1981;10(2):122-6.
1978: Whitehouse P; Caramazza A; Zurif E
Naming in aphasia: interacting effects of form and function.
Brain and language 1978;6(1):63-74.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Peter Whitehouse

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Procedures

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Peter Whitehouse (preview)

All Publications